nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Hydromorphone—PTGS1—kidney cancer	0.00297	0.326	CrCbGaD
Nalbuphine—Rash—Temsirolimus—kidney cancer	0.00241	0.00243	CcSEcCtD
Nalbuphine—Dermatitis—Temsirolimus—kidney cancer	0.0024	0.00243	CcSEcCtD
Nalbuphine—Headache—Temsirolimus—kidney cancer	0.00239	0.00241	CcSEcCtD
Nalbuphine—Dizziness—Pazopanib—kidney cancer	0.00238	0.0024	CcSEcCtD
Nalbuphine—Oedema—Sunitinib—kidney cancer	0.00237	0.00239	CcSEcCtD
Nalbuphine—Feeling abnormal—Vinblastine—kidney cancer	0.00235	0.00237	CcSEcCtD
Nalbuphine—Injection site reaction—Doxorubicin—kidney cancer	0.00235	0.00237	CcSEcCtD
Nalbuphine—Feeling abnormal—Everolimus—kidney cancer	0.00234	0.00236	CcSEcCtD
Nalbuphine—Shock—Sunitinib—kidney cancer	0.00233	0.00235	CcSEcCtD
Nalbuphine—Erythema—Gemcitabine—kidney cancer	0.00233	0.00235	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Vinblastine—kidney cancer	0.00233	0.00235	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Everolimus—kidney cancer	0.00232	0.00234	CcSEcCtD
Nalbuphine—Asthma—Capecitabine—kidney cancer	0.0023	0.00232	CcSEcCtD
Nalbuphine—Vomiting—Pazopanib—kidney cancer	0.00229	0.00231	CcSEcCtD
Nalbuphine—Bradycardia—Paclitaxel—kidney cancer	0.00228	0.0023	CcSEcCtD
Nalbuphine—Rash—Pazopanib—kidney cancer	0.00227	0.00229	CcSEcCtD
Nalbuphine—Nausea—Temsirolimus—kidney cancer	0.00227	0.00229	CcSEcCtD
Nalbuphine—Dermatitis—Pazopanib—kidney cancer	0.00227	0.00229	CcSEcCtD
Nalbuphine—Bronchospasm—Capecitabine—kidney cancer	0.00226	0.00228	CcSEcCtD
Nalbuphine—Agitation—Vincristine—kidney cancer	0.00226	0.00228	CcSEcCtD
Nalbuphine—Abdominal pain—Vinblastine—kidney cancer	0.00225	0.00227	CcSEcCtD
Nalbuphine—Headache—Pazopanib—kidney cancer	0.00225	0.00227	CcSEcCtD
Nalbuphine—Oedema—Dactinomycin—kidney cancer	0.00225	0.00227	CcSEcCtD
Nalbuphine—Abdominal pain—Everolimus—kidney cancer	0.00224	0.00227	CcSEcCtD
Nalbuphine—Body temperature increased—Everolimus—kidney cancer	0.00224	0.00227	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Erlotinib—kidney cancer	0.00224	0.00226	CcSEcCtD
Nalbuphine—Sweating increased—Capecitabine—kidney cancer	0.00224	0.00226	CcSEcCtD
Nalbuphine—Hypoaesthesia—Paclitaxel—kidney cancer	0.00223	0.00225	CcSEcCtD
Nalbuphine—Vertigo—Vincristine—kidney cancer	0.00221	0.00223	CcSEcCtD
Nalbuphine—Dyspnoea—Sorafenib—kidney cancer	0.0022	0.00222	CcSEcCtD
Nalbuphine—Dyspepsia—Sorafenib—kidney cancer	0.00217	0.00219	CcSEcCtD
Nalbuphine—Body temperature increased—Erlotinib—kidney cancer	0.00217	0.00219	CcSEcCtD
Nalbuphine—Abdominal pain—Erlotinib—kidney cancer	0.00217	0.00219	CcSEcCtD
Nalbuphine—Nausea—Pazopanib—kidney cancer	0.00214	0.00216	CcSEcCtD
Nalbuphine—Paraesthesia—Sunitinib—kidney cancer	0.00213	0.00215	CcSEcCtD
Nalbuphine—Convulsion—Vincristine—kidney cancer	0.00213	0.00215	CcSEcCtD
Nalbuphine—Hypertension—Vincristine—kidney cancer	0.00212	0.00214	CcSEcCtD
Nalbuphine—Dyspnoea—Sunitinib—kidney cancer	0.00211	0.00213	CcSEcCtD
Nalbuphine—Pulmonary oedema—Doxorubicin—kidney cancer	0.0021	0.00212	CcSEcCtD
Nalbuphine—Hypersensitivity—Vinblastine—kidney cancer	0.0021	0.00212	CcSEcCtD
Nalbuphine—Hypersensitivity—Everolimus—kidney cancer	0.00209	0.00211	CcSEcCtD
Nalbuphine—Dyspepsia—Sunitinib—kidney cancer	0.00209	0.00211	CcSEcCtD
Nalbuphine—Flushing—Paclitaxel—kidney cancer	0.00208	0.0021	CcSEcCtD
Nalbuphine—Asthenia—Vinblastine—kidney cancer	0.00205	0.00206	CcSEcCtD
Nalbuphine—Depression—Capecitabine—kidney cancer	0.00204	0.00206	CcSEcCtD
Nalbuphine—Asthenia—Everolimus—kidney cancer	0.00204	0.00206	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Sorafenib—kidney cancer	0.00202	0.00203	CcSEcCtD
Nalbuphine—Hypertension—Gemcitabine—kidney cancer	0.00201	0.00203	CcSEcCtD
Nalbuphine—Pruritus—Everolimus—kidney cancer	0.00201	0.00203	CcSEcCtD
Nalbuphine—Oedema—Vincristine—kidney cancer	0.00201	0.00202	CcSEcCtD
Nalbuphine—Naltrexone—ABCB1—kidney cancer	0.002	0.219	CrCbGaD
Nalbuphine—Asthenia—Erlotinib—kidney cancer	0.00197	0.00198	CcSEcCtD
Nalbuphine—Urticaria—Sorafenib—kidney cancer	0.00196	0.00198	CcSEcCtD
Nalbuphine—Erythema—Paclitaxel—kidney cancer	0.00195	0.00197	CcSEcCtD
Nalbuphine—Abdominal pain—Sorafenib—kidney cancer	0.00195	0.00197	CcSEcCtD
Nalbuphine—Body temperature increased—Sorafenib—kidney cancer	0.00195	0.00197	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Sunitinib—kidney cancer	0.00194	0.00196	CcSEcCtD
Nalbuphine—Hyperhidrosis—Vincristine—kidney cancer	0.00194	0.00196	CcSEcCtD
Nalbuphine—Pruritus—Erlotinib—kidney cancer	0.00194	0.00196	CcSEcCtD
Nalbuphine—Tension—Paclitaxel—kidney cancer	0.00192	0.00193	CcSEcCtD
Nalbuphine—Dysgeusia—Paclitaxel—kidney cancer	0.00191	0.00193	CcSEcCtD
Nalbuphine—Oedema—Gemcitabine—kidney cancer	0.0019	0.00192	CcSEcCtD
Nalbuphine—Nervousness—Paclitaxel—kidney cancer	0.0019	0.00191	CcSEcCtD
Nalbuphine—Dizziness—Vinblastine—kidney cancer	0.00188	0.0019	CcSEcCtD
Nalbuphine—Dizziness—Everolimus—kidney cancer	0.00188	0.00189	CcSEcCtD
Nalbuphine—Muscle spasms—Paclitaxel—kidney cancer	0.00188	0.00189	CcSEcCtD
Nalbuphine—Abdominal pain—Sunitinib—kidney cancer	0.00187	0.00189	CcSEcCtD
Nalbuphine—Body temperature increased—Sunitinib—kidney cancer	0.00187	0.00189	CcSEcCtD
Nalbuphine—Hypotension—Vincristine—kidney cancer	0.00187	0.00189	CcSEcCtD
Nalbuphine—Bradycardia—Capecitabine—kidney cancer	0.00187	0.00189	CcSEcCtD
Nalbuphine—Feeling abnormal—Dactinomycin—kidney cancer	0.00185	0.00187	CcSEcCtD
Nalbuphine—Vision blurred—Paclitaxel—kidney cancer	0.00184	0.00186	CcSEcCtD
Nalbuphine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00184	0.00186	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00184	0.00185	CcSEcCtD
Nalbuphine—Hypoaesthesia—Capecitabine—kidney cancer	0.00183	0.00185	CcSEcCtD
Nalbuphine—Tremor—Paclitaxel—kidney cancer	0.00183	0.00185	CcSEcCtD
Nalbuphine—Hypersensitivity—Sorafenib—kidney cancer	0.00182	0.00183	CcSEcCtD
Nalbuphine—Vomiting—Vinblastine—kidney cancer	0.00181	0.00183	CcSEcCtD
Nalbuphine—Dizziness—Erlotinib—kidney cancer	0.00181	0.00183	CcSEcCtD
Nalbuphine—Vomiting—Everolimus—kidney cancer	0.00181	0.00182	CcSEcCtD
Nalbuphine—Paraesthesia—Vincristine—kidney cancer	0.0018	0.00182	CcSEcCtD
Nalbuphine—Agitation—Paclitaxel—kidney cancer	0.00179	0.00181	CcSEcCtD
Nalbuphine—Rash—Everolimus—kidney cancer	0.00179	0.00181	CcSEcCtD
Nalbuphine—Dermatitis—Everolimus—kidney cancer	0.00179	0.00181	CcSEcCtD
Nalbuphine—Headache—Vinblastine—kidney cancer	0.00179	0.0018	CcSEcCtD
Nalbuphine—Headache—Everolimus—kidney cancer	0.00178	0.0018	CcSEcCtD
Nalbuphine—Hypotension—Gemcitabine—kidney cancer	0.00178	0.00179	CcSEcCtD
Nalbuphine—Body temperature increased—Dactinomycin—kidney cancer	0.00177	0.00179	CcSEcCtD
Nalbuphine—Abdominal pain—Dactinomycin—kidney cancer	0.00177	0.00179	CcSEcCtD
Nalbuphine—Asthenia—Sorafenib—kidney cancer	0.00177	0.00178	CcSEcCtD
Nalbuphine—Vertigo—Paclitaxel—kidney cancer	0.00175	0.00177	CcSEcCtD
Nalbuphine—Syncope—Paclitaxel—kidney cancer	0.00175	0.00177	CcSEcCtD
Nalbuphine—Hypersensitivity—Sunitinib—kidney cancer	0.00175	0.00176	CcSEcCtD
Nalbuphine—Pruritus—Sorafenib—kidney cancer	0.00174	0.00176	CcSEcCtD
Nalbuphine—Vomiting—Erlotinib—kidney cancer	0.00174	0.00176	CcSEcCtD
Nalbuphine—Rash—Erlotinib—kidney cancer	0.00173	0.00174	CcSEcCtD
Nalbuphine—Dermatitis—Erlotinib—kidney cancer	0.00173	0.00174	CcSEcCtD
Nalbuphine—Headache—Erlotinib—kidney cancer	0.00172	0.00173	CcSEcCtD
Nalbuphine—Loss of consciousness—Paclitaxel—kidney cancer	0.00172	0.00173	CcSEcCtD
Nalbuphine—Paraesthesia—Gemcitabine—kidney cancer	0.00171	0.00172	CcSEcCtD
Nalbuphine—Flushing—Capecitabine—kidney cancer	0.00171	0.00172	CcSEcCtD
Nalbuphine—Asthenia—Sunitinib—kidney cancer	0.0017	0.00172	CcSEcCtD
Nalbuphine—Dyspnoea—Gemcitabine—kidney cancer	0.0017	0.00171	CcSEcCtD
Nalbuphine—Nausea—Vinblastine—kidney cancer	0.00169	0.00171	CcSEcCtD
Nalbuphine—Somnolence—Gemcitabine—kidney cancer	0.00169	0.00171	CcSEcCtD
Nalbuphine—Convulsion—Paclitaxel—kidney cancer	0.00169	0.00171	CcSEcCtD
Nalbuphine—Nausea—Everolimus—kidney cancer	0.00169	0.0017	CcSEcCtD
Nalbuphine—Hypertension—Paclitaxel—kidney cancer	0.00169	0.0017	CcSEcCtD
Nalbuphine—Pruritus—Sunitinib—kidney cancer	0.00168	0.00169	CcSEcCtD
Nalbuphine—Anxiety—Paclitaxel—kidney cancer	0.00166	0.00167	CcSEcCtD
Nalbuphine—Hypersensitivity—Dactinomycin—kidney cancer	0.00165	0.00167	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Vincristine—kidney cancer	0.00164	0.00166	CcSEcCtD
Nalbuphine—Cardiac arrest—Doxorubicin—kidney cancer	0.00163	0.00165	CcSEcCtD
Nalbuphine—Dizziness—Sorafenib—kidney cancer	0.00163	0.00164	CcSEcCtD
Nalbuphine—Nausea—Erlotinib—kidney cancer	0.00163	0.00164	CcSEcCtD
Nalbuphine—Dry mouth—Paclitaxel—kidney cancer	0.00163	0.00164	CcSEcCtD
Nalbuphine—Asthenia—Dactinomycin—kidney cancer	0.00161	0.00163	CcSEcCtD
Nalbuphine—Confusional state—Paclitaxel—kidney cancer	0.00161	0.00162	CcSEcCtD
Nalbuphine—Erythema—Capecitabine—kidney cancer	0.0016	0.00162	CcSEcCtD
Nalbuphine—Oedema—Paclitaxel—kidney cancer	0.00159	0.00161	CcSEcCtD
Nalbuphine—Body temperature increased—Vincristine—kidney cancer	0.00159	0.0016	CcSEcCtD
Nalbuphine—Abdominal pain—Vincristine—kidney cancer	0.00159	0.0016	CcSEcCtD
Nalbuphine—Dysgeusia—Capecitabine—kidney cancer	0.00157	0.00158	CcSEcCtD
Nalbuphine—Dizziness—Sunitinib—kidney cancer	0.00157	0.00158	CcSEcCtD
Nalbuphine—Feeling abnormal—Gemcitabine—kidney cancer	0.00157	0.00158	CcSEcCtD
Nalbuphine—Shock—Paclitaxel—kidney cancer	0.00157	0.00158	CcSEcCtD
Nalbuphine—Vomiting—Sorafenib—kidney cancer	0.00157	0.00158	CcSEcCtD
Nalbuphine—Tachycardia—Paclitaxel—kidney cancer	0.00155	0.00157	CcSEcCtD
Nalbuphine—Rash—Sorafenib—kidney cancer	0.00155	0.00157	CcSEcCtD
Nalbuphine—Dermatitis—Sorafenib—kidney cancer	0.00155	0.00157	CcSEcCtD
Nalbuphine—Headache—Sorafenib—kidney cancer	0.00154	0.00156	CcSEcCtD
Nalbuphine—Muscle spasms—Capecitabine—kidney cancer	0.00154	0.00155	CcSEcCtD
Nalbuphine—Hyperhidrosis—Paclitaxel—kidney cancer	0.00154	0.00155	CcSEcCtD
Nalbuphine—Vision blurred—Capecitabine—kidney cancer	0.00151	0.00152	CcSEcCtD
Nalbuphine—Vomiting—Sunitinib—kidney cancer	0.00151	0.00152	CcSEcCtD
Nalbuphine—Body temperature increased—Gemcitabine—kidney cancer	0.0015	0.00152	CcSEcCtD
Nalbuphine—Tremor—Capecitabine—kidney cancer	0.0015	0.00151	CcSEcCtD
Nalbuphine—Rash—Sunitinib—kidney cancer	0.0015	0.00151	CcSEcCtD
Nalbuphine—Dermatitis—Sunitinib—kidney cancer	0.00149	0.00151	CcSEcCtD
Nalbuphine—Hypotension—Paclitaxel—kidney cancer	0.00149	0.0015	CcSEcCtD
Nalbuphine—Headache—Sunitinib—kidney cancer	0.00149	0.0015	CcSEcCtD
Nalbuphine—Asthma—Doxorubicin—kidney cancer	0.00148	0.0015	CcSEcCtD
Nalbuphine—Hypersensitivity—Vincristine—kidney cancer	0.00148	0.00149	CcSEcCtD
Nalbuphine—Buprenorphine—ABCB1—kidney cancer	0.00147	0.161	CrCbGaD
Nalbuphine—Nausea—Sorafenib—kidney cancer	0.00146	0.00148	CcSEcCtD
Nalbuphine—Naloxone—ABCB1—kidney cancer	0.00146	0.16	CrCbGaD
Nalbuphine—Vertigo—Capecitabine—kidney cancer	0.00144	0.00145	CcSEcCtD
Nalbuphine—Asthenia—Vincristine—kidney cancer	0.00144	0.00145	CcSEcCtD
Nalbuphine—Syncope—Capecitabine—kidney cancer	0.00144	0.00145	CcSEcCtD
Nalbuphine—Paraesthesia—Paclitaxel—kidney cancer	0.00143	0.00144	CcSEcCtD
Nalbuphine—Vomiting—Dactinomycin—kidney cancer	0.00143	0.00144	CcSEcCtD
Nalbuphine—Dyspnoea—Paclitaxel—kidney cancer	0.00142	0.00143	CcSEcCtD
Nalbuphine—Somnolence—Paclitaxel—kidney cancer	0.00142	0.00143	CcSEcCtD
Nalbuphine—Rash—Dactinomycin—kidney cancer	0.00142	0.00143	CcSEcCtD
Nalbuphine—Nausea—Sunitinib—kidney cancer	0.00141	0.00142	CcSEcCtD
Nalbuphine—Loss of consciousness—Capecitabine—kidney cancer	0.00141	0.00142	CcSEcCtD
Nalbuphine—Dyspepsia—Paclitaxel—kidney cancer	0.0014	0.00142	CcSEcCtD
Nalbuphine—Hypertension—Capecitabine—kidney cancer	0.00138	0.0014	CcSEcCtD
Nalbuphine—Pollakiuria—Doxorubicin—kidney cancer	0.00137	0.00138	CcSEcCtD
Nalbuphine—Asthenia—Gemcitabine—kidney cancer	0.00137	0.00138	CcSEcCtD
Nalbuphine—Anxiety—Capecitabine—kidney cancer	0.00136	0.00137	CcSEcCtD
Nalbuphine—Pruritus—Gemcitabine—kidney cancer	0.00135	0.00136	CcSEcCtD
Nalbuphine—Dry mouth—Capecitabine—kidney cancer	0.00133	0.00135	CcSEcCtD
Nalbuphine—Nausea—Dactinomycin—kidney cancer	0.00133	0.00135	CcSEcCtD
Nalbuphine—Dizziness—Vincristine—kidney cancer	0.00133	0.00134	CcSEcCtD
Nalbuphine—Confusional state—Capecitabine—kidney cancer	0.00132	0.00133	CcSEcCtD
Nalbuphine—Feeling abnormal—Paclitaxel—kidney cancer	0.00131	0.00133	CcSEcCtD
Nalbuphine—Oedema—Capecitabine—kidney cancer	0.00131	0.00132	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.0013	0.00131	CcSEcCtD
Nalbuphine—Shock—Capecitabine—kidney cancer	0.00129	0.0013	CcSEcCtD
Nalbuphine—Tachycardia—Capecitabine—kidney cancer	0.00128	0.00129	CcSEcCtD
Nalbuphine—Vomiting—Vincristine—kidney cancer	0.00128	0.00129	CcSEcCtD
Nalbuphine—Urticaria—Paclitaxel—kidney cancer	0.00127	0.00128	CcSEcCtD
Nalbuphine—Rash—Vincristine—kidney cancer	0.00126	0.00128	CcSEcCtD
Nalbuphine—Hyperhidrosis—Capecitabine—kidney cancer	0.00126	0.00128	CcSEcCtD
Nalbuphine—Dermatitis—Vincristine—kidney cancer	0.00126	0.00128	CcSEcCtD
Nalbuphine—Body temperature increased—Paclitaxel—kidney cancer	0.00126	0.00127	CcSEcCtD
Nalbuphine—Abdominal pain—Paclitaxel—kidney cancer	0.00126	0.00127	CcSEcCtD
Nalbuphine—Headache—Vincristine—kidney cancer	0.00126	0.00127	CcSEcCtD
Nalbuphine—Morphine—ABCB1—kidney cancer	0.00123	0.135	CrCbGaD
Nalbuphine—Hypotension—Capecitabine—kidney cancer	0.00122	0.00123	CcSEcCtD
Nalbuphine—Vomiting—Gemcitabine—kidney cancer	0.00121	0.00122	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—kidney cancer	0.00121	0.00122	CcSEcCtD
Nalbuphine—Rash—Gemcitabine—kidney cancer	0.0012	0.00121	CcSEcCtD
Nalbuphine—Dermatitis—Gemcitabine—kidney cancer	0.0012	0.00121	CcSEcCtD
Nalbuphine—Headache—Gemcitabine—kidney cancer	0.00119	0.0012	CcSEcCtD
Nalbuphine—Nausea—Vincristine—kidney cancer	0.00119	0.0012	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—kidney cancer	0.00118	0.00119	CcSEcCtD
Nalbuphine—Paraesthesia—Capecitabine—kidney cancer	0.00117	0.00118	CcSEcCtD
Nalbuphine—Hypersensitivity—Paclitaxel—kidney cancer	0.00117	0.00118	CcSEcCtD
Nalbuphine—Dyspnoea—Capecitabine—kidney cancer	0.00117	0.00118	CcSEcCtD
Nalbuphine—Dyspepsia—Capecitabine—kidney cancer	0.00115	0.00116	CcSEcCtD
Nalbuphine—Asthenia—Paclitaxel—kidney cancer	0.00114	0.00115	CcSEcCtD
Nalbuphine—Nausea—Gemcitabine—kidney cancer	0.00113	0.00114	CcSEcCtD
Nalbuphine—Pruritus—Paclitaxel—kidney cancer	0.00113	0.00114	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—kidney cancer	0.0011	0.00111	CcSEcCtD
Nalbuphine—Feeling abnormal—Capecitabine—kidney cancer	0.00108	0.00109	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Capecitabine—kidney cancer	0.00107	0.00108	CcSEcCtD
Nalbuphine—Dizziness—Paclitaxel—kidney cancer	0.00105	0.00106	CcSEcCtD
Nalbuphine—Urticaria—Capecitabine—kidney cancer	0.00104	0.00105	CcSEcCtD
Nalbuphine—Abdominal pain—Capecitabine—kidney cancer	0.00103	0.00104	CcSEcCtD
Nalbuphine—Body temperature increased—Capecitabine—kidney cancer	0.00103	0.00104	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—kidney cancer	0.00103	0.00104	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—kidney cancer	0.00101	0.00102	CcSEcCtD
Nalbuphine—Vomiting—Paclitaxel—kidney cancer	0.00101	0.00102	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—kidney cancer	0.00101	0.00102	CcSEcCtD
Nalbuphine—Rash—Paclitaxel—kidney cancer	0.001	0.00101	CcSEcCtD
Nalbuphine—Dermatitis—Paclitaxel—kidney cancer	0.001	0.00101	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—kidney cancer	0.001	0.00101	CcSEcCtD
Nalbuphine—Headache—Paclitaxel—kidney cancer	0.000998	0.00101	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—kidney cancer	0.000993	0.001	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—kidney cancer	0.000973	0.000982	CcSEcCtD
Nalbuphine—Hypersensitivity—Capecitabine—kidney cancer	0.000963	0.000972	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—kidney cancer	0.000949	0.000958	CcSEcCtD
Nalbuphine—Nausea—Paclitaxel—kidney cancer	0.000946	0.000955	CcSEcCtD
Nalbuphine—Asthenia—Capecitabine—kidney cancer	0.000938	0.000947	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—kidney cancer	0.000928	0.000936	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—kidney cancer	0.000926	0.000935	CcSEcCtD
Nalbuphine—Pruritus—Capecitabine—kidney cancer	0.000925	0.000934	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—kidney cancer	0.000908	0.000916	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—kidney cancer	0.000895	0.000903	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—kidney cancer	0.000892	0.0009	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—kidney cancer	0.000876	0.000884	CcSEcCtD
Nalbuphine—Dizziness—Capecitabine—kidney cancer	0.000865	0.000873	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—kidney cancer	0.00086	0.000868	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—kidney cancer	0.00085	0.000858	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—kidney cancer	0.000843	0.000851	CcSEcCtD
Nalbuphine—Vomiting—Capecitabine—kidney cancer	0.000831	0.000839	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—kidney cancer	0.000829	0.000837	CcSEcCtD
Nalbuphine—Rash—Capecitabine—kidney cancer	0.000824	0.000832	CcSEcCtD
Nalbuphine—Dermatitis—Capecitabine—kidney cancer	0.000824	0.000831	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—kidney cancer	0.000823	0.00083	CcSEcCtD
Nalbuphine—Headache—Capecitabine—kidney cancer	0.000819	0.000827	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000815	0.000822	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—kidney cancer	0.000788	0.000795	CcSEcCtD
Nalbuphine—Nausea—Capecitabine—kidney cancer	0.000777	0.000784	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—kidney cancer	0.000757	0.000764	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—kidney cancer	0.000751	0.000758	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—kidney cancer	0.000749	0.000756	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—kidney cancer	0.000742	0.000749	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—kidney cancer	0.000695	0.000701	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000689	0.000696	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—kidney cancer	0.00067	0.000676	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—kidney cancer	0.000666	0.000672	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—kidney cancer	0.000666	0.000672	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—kidney cancer	0.000621	0.000627	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—kidney cancer	0.000605	0.00061	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—kidney cancer	0.000596	0.000602	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—kidney cancer	0.000557	0.000562	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—kidney cancer	0.000536	0.000541	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—kidney cancer	0.000531	0.000536	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—kidney cancer	0.000531	0.000536	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—kidney cancer	0.000528	0.000533	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—kidney cancer	0.000501	0.000505	CcSEcCtD
